Coronavirus disease 2019 (COVID‐19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin‐converting enzyme inhibitors/angiotensin …
J Guo, Z Huang, L Lin, J Lv - Journal of the American Heart …, 2020 - Am Heart Assoc
According to available clinical data,≈ 15% to 30% of the COVID-19 patients are with
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
[引用][C] Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors …
J Guo, Z Huang, L Lin, J Lv - Journal of the American Heart Association, 2020 - cir.nii.ac.jp
Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the
Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor …
Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor …
[PDF][PDF] See Article by Sommerstein et al.
J Guo, Z Huang, L Lin, J Lv - 2020 - scienceopen.com
According to available clinical data,≈ 15% to 30% of the COVID-19 patients are with
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
[HTML][HTML] Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors …
J Guo, Z Huang, L Lin, J Lv - Journal of the American Heart …, 2020 - ncbi.nlm.nih.gov
According to available clinical data,≈ 15% to 30% of the COVID-19 patients are with
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin …
J Guo, Z Huang, L Lin, J Lv - Journal of the American Heart …, 2020 - europepmc.org
The prevalence of coronavirus disease 2019 (COVID‐19) has posed a great threat to
people's health worldwide, bringing a great challenges to the public healthcare systems. A …
people's health worldwide, bringing a great challenges to the public healthcare systems. A …
[PDF][PDF] See Article by Sommerstein et al.
J Guo, Z Huang, L Lin, J Lv - 2020 - pdfs.semanticscholar.org
According to available clinical data,≈ 15% to 30% of the COVID-19 patients are with
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin …
J Guo, Z Huang, L Lin, J Lv - 2020 - cabidigitallibrary.org
The objective of the article was to present a viewpoint on the potential influence of
angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) …
angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) …
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin …
J Guo, Z Huang, L Lin, J Lv - Journal of the American …, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the
Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers …
Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers …
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin …
J Guo, Z Huang, L Lin, J Lv - Journal of the American Heart …, 2020 - europepmc.org
According to available clinical data,≈ 15% to 30% of the COVID-19 patients are with
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …
hypertension and≈ 2.5% to 15% are with coronary heart disease. 3–5 …